subscribeSubscribe
Lilly’s Jaypirca tipped to capture 60% of BTK leukemia market

Lilly’s Jaypirca tipped to capture 60% of BTK leukemia market
FIERCE PHARMA
22 Jan 2024
Share Share
Updated Data from the BRUIN Phase 1/2 Study of Pirtobrutinib Presented at ASH

Updated Data from the BRUIN Phase 1/2 Study of Pirtobrutinib Presented at ASH
PR NEWSWIRE
11 Dec 2023
Share Share
Lilly`s Jaypirca blazes CLL trail with FDA approval

Lilly`s Jaypirca blazes CLL trail with FDA approval
Angus Liu FIERCE PHARMA
04 Dec 2023
Share Share
US FDA gives second approval to Eli Lilly`s drug for type of blood cancer

US FDA gives second approval to Eli Lilly`s drug for type of blood cancer
PR NEWSWIRE
02 Dec 2023
Share Share
Eli Lilly`s Jaypirca (pirtobrutinib) Receives Approval in Europe

Eli Lilly`s Jaypirca (pirtobrutinib) Receives Approval in Europe
EMA
20 Nov 2023
Share Share
Lilly Announces Details of Pirtobrutinib Presentations in B-Cell Malignancies

Lilly Announces Details of Pirtobrutinib Presentations in B-Cell Malignancies
PR NEWSWIRE
02 Nov 2023
Share Share
Lilly Highlights Verzenio and Jaypirca Data at 2023 ASCO Annual Meeting

Lilly Highlights Verzenio and Jaypirca Data at 2023 ASCO Annual Meeting
PR NEWSWIRE
02 Jun 2023
Share Share
Lunsumio™, Jaypirca™ Available at AllianceRx Walgreens Pharmacy

Lunsumio™, Jaypirca™ Available at AllianceRx Walgreens Pharmacy
PR NEWSWIRE
17 May 2023
Share Share
JAYPIRCA™ (pirtobrutinib) Now Available from Onco360 for the Treatment of MCL

JAYPIRCA™ (pirtobrutinib) Now Available from Onco360 for the Treatment of MCL
BUSINESSWIRE
01 Feb 2023
Share Share
Eli Lilly`s Jaypirca gets US nod for mantle cell lymphoma

Eli Lilly`s Jaypirca gets US nod for mantle cell lymphoma
Kyle LaHucik ENDPTS
28 Jan 2023
Share Share